| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |